NEUROCRINE BIOSCIENCES INC
NBIX
54 insider filings · Latest: Jun 26, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jan 15, 2025 | Jan 15 9:19 PM | KYLE W GANO | Proposed Sale | 65,000 | $139.51 | $9.1M | — | View → |
| Dec 31, 2024 | Dec 31 9:17 PM | INGRID DELAET | Proposed Sale | 272 | $137.06 | $37.3K | — | View → |
| Dec 17, 2024 | Dec 17 9:29 PM | INGRID DELAET | Proposed Sale | 1,091 | $133.05 | $145.2K | — | View → |
| Nov 29, 2024 | Nov 29 6:41 PM | JUDE ONYIA | Proposed Sale | 2,331 | $126.59 | $295.1K | — | View → |
| Sep 13, 2024 | Sep 13 8:23 PM | DAVID WARREN BOYER | Proposed Sale | 4,756 | $121.28 | $576.8K | — | View → |
← Previous
Page 5 of 5
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jan 31, 2026 | Feb 3 11:03 PM | Kyle GanoDirector, Chief Executive Officer | Option Exercise | 2,927 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 11:02 PM | Kevin Charles GormanDirector | Option Exercise | 5,142 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 11:01 PM | Darin LippoldtChief Legal Officer | Option Exercise | 2,373 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 11:01 PM | Jude OnyiaChief Scientific Officer | Option Exercise | 238 | — | 0(D) | View → |
| Jan 16, 2026 | Jan 20 11:56 PM | Kyle GanoDirector, Chief Executive Officer | Option Exercise | 36,400 | $35.99 | 0(D) | View → |
← Previous
Page 4 of 4